Even if they gave the company to the junior bond holders and extended the senior bank debt, it is still too much debt. Another BK would have to be filed later when time to pay back. Extensions only delay BK actions.. Give this damn company to the all the debt holders in BK and be done with it. Make the blood suckers own this pig.
Agreement was announced last August to pursue the approval. Since we have USA approval results should be on the fast track. I think it is reasonable to conclude global approval should be in hand from anywhere last quarter 2015 to the end of 2016. If longs are feeling down just remember this: It is much easier for Affrezza to transform the diabetic market than for Tesla to transform the combustion engine market. Afrezza is better than the competition and can be matched on price NOW!
..give it a year. If there is anything to this drug and company, we should know by then. Potential is overwhelmingly present, market is not going to reward potential, news will have do the driving...only thing that is going to work now. We don't need management hype, we need results. Hakam said significant uptake in the last quarter of this year. We will see. MNKD will be a punching bag for shorts until news time.